NeueHealth, Inc. (NEUE)
- Previous Close
5.80 - Open
5.75 - Bid 5.40 x 1400
- Ask 5.95 x 1100
- Day's Range
5.55 - 5.78 - 52 Week Range
4.94 - 22.00 - Volume
11,189 - Avg. Volume
8,869 - Market Cap (intraday)
45.647M - Beta (5Y Monthly) 0.79
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 7, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
20.67
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
www.neuehealth.comRecent News: NEUE
Performance Overview: NEUE
Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NEUE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NEUE
Valuation Measures
Market Cap
45.65M
Enterprise Value
919.70M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.04
Price/Book (mrq)
--
Enterprise Value/Revenue
0.83
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-89.78%
Return on Assets (ttm)
-3.09%
Return on Equity (ttm)
-202.22%
Revenue (ttm)
1.11B
Net Income Avi to Common (ttm)
-509.82M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
112.76M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
57.12M